Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

o-ethyldioleoylphosphatidylcholinium

Known as: EDOPC 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
mRNA-based vaccines have the benefit of triggering robust anti-cancer immunity without the potential danger of genome integration… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2008
2008
Synthetic cationic lipids can be used as DNA carriers and are regarded to be the most promising non-viral gene carriers. For this… Expand
2008
2008
The transfection activity and the phase behavior of two novel cationic O-alkyl-phosphatidylcholines, 1,2-dioleoyl- sn-glycero-3… Expand
Highly Cited
2007
Highly Cited
2007
Lipoplexes containing a mixture of cationic phospholipids dioleoylethylphosphatidylcholine (EDOPC) and… Expand
2006
2006
A combination of two cationic lipid derivatives having the same headgroup but tails of different chain lengths has been shown to… Expand
2006
2006
A unique method is described for directly observing the lateral organization of a membrane protein (bacterial light-harvesting… Expand
2004
2004
Phospholipid-DNA complexes were made of the cationic triester derivative of phosphatidylcholine, EDOPC (1,2-dioleoyl-sn-glycero-3… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2003
2003
Cationic, O-alkylphosphatidylcholines, recently developed as DNA transfection agents, form bilayers indistinguishable from those… Expand
  • figure 1
  • figure 2
Highly Cited
2000
Highly Cited
2000
The interaction of DNA with a novel cationic phospholipid transfection reagent, 1,2-dioleoyl-sn-glycero-3-ethylphosphocholine… Expand
Highly Cited
2000
Highly Cited
2000
1,2-Dioleoyl-sn-3-ethylphosphocholine (EDOPC) has been previously shown be a highly effective DNA transfection reagent in vitro… Expand